• 2019-07
  • 2019-08
  • 2019-09
  • 2019-10
  • 2019-11
  • 2020-03
  • 2020-07
  • 2020-08
  • 2021-03
  • br Panebianco V Barentsz J Narumi Y Catto


    [4] Panebianco V, Barentsz J, Narumi Y, Catto J, CBVI-RADS authors. Reply to Andrea Necchi, Antonella Messina, and Alberto Briganti's Letter to the Editor re: Valeria Panebianco, Yoshifumi Narumi, Ersan Altun, et al. Multiparametric magnetic resonance imaging for 555-60-2 can-cer: development of VI-RADS (Vesical Imaging-Reporting and Data System). Eur Urol 2018;74:294–306, [Eur Urol 2018;74:e109].
    [5] Panebianco V, Narumi Y, Altun E, et al. Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting and Data System). Eur Urol 2018;74:294–306.
    [6] Thoeny HC, Forstner R, De Keyzer F. Genitourinary applications of diffusion-weighted MR imaging in the pelvis. Radiology 2012;263:326–42.
    [7] Lughezzani G, Buffi NM, Lazzeri M. Diagnostic pathway of patients with a clinical suspicion of prostate cancer: does one size fit all? Eur Urol 2018;74:400–1. [8] Lughezzani G, Saita A, Lazzeri M, et al. Comparison of the diagnostic accuracy of micro-ultrasound and magnetic resonance imaging/ ultrasound fusion targeted biopsies for the diagnosis of clinically significant prostate cancer. Eur Urol Oncol. In press. 10.1016/j.euo.2018.10.001.
    [10] Eble J, Sauter G, Epstein J, Sesterhenn I. Pathology and genetics: tumours of the urinary system and male genital organs2004 World Health Organization classification of tumours; v 6s. Lyon, France: IARC Press, International Agency for Research on Cancer; 2004.
    [11] Sobin L, Gospodariwicz M, Wittekind C. International Union Against Cancer. TNM classification of malignant tumours. 7th ed. Oxford, UK: Wiley-Blackwell; 2009.
    [12] Ibanez Munoz D, Quintana Martinez I, Fernandez Militino A, San-chez Zalabardo D, Sarria Octavio de Toledo L, Cozcolluela Cabrejas R. Virtual cystoscopy, computed tomography urography and optical cystoscopy for the detection and follow-up for bladder cancer. Radiologia 2017;59:422–30.
    [13] Wang HJ, Pui MH, Guan J, et al. Comparison of early submucosal enhancement and tumor stalk in staging bladder urothelial carci-noma. AJR Am J Roentgenol 2016;207:797–803.
    [15] Teoh JYC, Herrmann TRW, Babjuk M, Panebianco Valeria, Yoshifumi Narumi, Altun Ersan, et al. Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Im-aging-Reporting and Data System). Eur Urol 2018;74:294–306, [Eur Urol 2019;75:e27–8].
    [16] Thoeny HC, Bellin MF, Comperat EM, Thalmann GN. Vesical Imag-ing-Reporting and Data System (VI-RADS): added value for man-agement of bladder cancer patients? Eur Urol 2018;74:307–8.
    [17] Ghai S, Eure G, Fradet V, et al. Assessing cancer risk on novel 29 MHz micro-ultrasound images of the prostate: creation of the micro-ultrasound protocol for prostate risk identification. J Urol 2016;196:562–9.
    [18] Pavlovich CP, Cornish TC, Mullins JK, et al. High-resolution transrectal ultrasound: pilot study of a novel technique for imaging clinically localized prostate cancer. Urol Oncol 2014;32(34):e27–32.
    [19] Mueller-Lisse U, Mueller-Lisse U, Scheidler J, Klein G, Reiser M. Reproducibility of image interpretation in MRI of the prostate: application of the sextant framework by two different radiologists. Eur Radiol 2005;15:1826–33.
    [20] Nogueira L, Wang L, Fine SW, et al. Focal treatment or observation of prostate cancer: pretreatment accuracy of transrectal ultrasound biopsy and T2-weighted MRI. Urology 2010;75:472–7.
    [21] Grimm MO, Steinhoff C, Simon X, Spiegelhalder P, Ackermann R, Vogeli TA. Effect of routine repeat transurethral resection for su-perficial bladder cancer: a long-term observational study. J Urol 2003;170(2 Pt 1):433–7.
    [22] Divrik RT, Yildirim U, Zorlu F, Ozen H. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. J Urol 2006;175:1641–4.
    Please cite this article in press as: Saita A, et al. Assessing the Feasibility and Accuracy of High-resolution Microultrasound Imaging for Bladder Cancer Detection and Staging. Eur Urol (2019), 
    Original article
    Assessing trends in urinary diversion after radical cystectomy for bladder cancer in the United States
    a USC Institute of Urology, Los Angeles, CA b University of Southern California, Los Angeles, CA c USC/Norris Comprehensive Cancer Center, Los Angeles, CA
    Objectives: We assessed recent trends in both urinary diversion after radical cystectomy for bladder cancer in the United States and patient- and hospital-related characteristics. We also identified variables associated with undergoing continent diversion.